Screening Committee: Chairman

HealthTech capital members serve for rotating terms on the Screening Committee. These members have experience with the HealthTech stakeholders including business solutions for providers, payers and patients. Our members’ expertise covers Digital Health, Pharmaceuticals & Therapeutics, Medical Device & Instrumentation, Drug Discoveries, Diagnostics and Healthcare Services.

Carl Bouthillette

Chairman Screening Committee

Carl Bouthillette

Carl has over 25 years of medical device and biotechnology experience, and is passionate about helping entrepreneurs succeed in the emerging HealthTech sector. He is the Co-chair of HealthTech Capital’s screening committee and enjoys working and mentoring startup CEOs.

Prior to founding Metis Lighthouse, Carl served in leadership roles at Abbott and Guidant in general management, global marketing, new product development, and geography marketing. He has experience leading teams in Asia, Europe, Canada, and the United States. Prior to joining Guidant, Carl was a successful entrepreneur with a leading custom DNA, peptides, and genes startup. Carl holds a B.S. degree in biomedical science from Texas A&M University, and an MBA from INSEAD in France.


Do you charge companies to present?Absolutely not! HTC does not charge application or presentation fees. Because HealthTech Capital provides significant added value to companies, such as leading a term sheet, strategic advice, industry connections, mentoring, board members and board observers, common stock options are expected in exchange for these services.


© 2011 HealthTech Capital. All Rights Reserved. Designed by Night River